A recent study has revealed that exhausted T cells, which were previously thought to be ineffective, can actually lose their exhaustion marker LAG3 and break free from tumors. This escape enables them to offer long-lasting immunity against cancer relapse, opening up new avenues for cancer treatment.
Key Insights
The study's findings highlight that exhausted T cells can ditch the LAG3 marker and escape from tumors, leading to a durable immune response. Furthermore, this discovery has the potential to improve LAG3-targeting cancer immunotherapies, which could lead to more effective treatments and better patient outcomes.










